Sera Prognostics (SERA)

• Market cap: $128M
• 1 day: -0.29%
• 5 days: 3.04%
• 1 month: -10.55%
• 3 months: -48.95%
• 6 months: -53.69%
• Year to date: -59.30%
• 1 year: -65.30%
• 5 years: -71.51%
• 10 years: -71.51%
• Sector: Healthcare
• Industry: Medical Devices

About: Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

Employees: 64

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

217% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 6

133% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 12

21% more funds holding

Funds holding: 61 [Q3] → 74 (+13) [Q4]

5% more capital invested

Capital invested by funds: $140M [Q3] → $147M (+$6.89M) [Q4]

0.36% less ownership

Funds ownership: 55.53% [Q3] → 55.18% (-0.36%) [Q4]

35% less call options, than puts

Call options by funds: $235K | Put options by funds: $361K